eASCVDT2DMASCVDType 2 Diabetesglucagon-like peptide-1 analoguessodium-glucose cotransporter-2 inhibitorsESC
…ith high risk of ASCVD and without eASCVD.Results Prevalence of eASCVD was 108/550 (19.6%, 95% CI 16.5% to 23.2%), and the prevalence …
1articles mentioning diseases
6disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: eASCVD ×
eASCVD
This disease is selected. Its supporting articles are shown below.